218 related articles for article (PubMed ID: 9380049)
1. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
3. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
[TBL] [Abstract][Full Text] [Related]
4. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
5. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
6. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
7. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy].
Kondo S; Tanaka M; Sun X; Okamoto K; Hirai S
Rinsho Shinkeigaku; 1994 Jun; 34(6):531-7. PubMed ID: 7955710
[TBL] [Abstract][Full Text] [Related]
9. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls.
Markus HS; Lees AJ; Lennox G; Marsden CD; Costa DC
Mov Disord; 1995 Mar; 10(2):179-87. PubMed ID: 7753060
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
11. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
12. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
13. [Neuroimaging features in progressive supranuclear palsy and corticobasal degeneration].
Mori E
Rinsho Shinkeigaku; 2002 Nov; 42(11):1158-61. PubMed ID: 12784693
[TBL] [Abstract][Full Text] [Related]
14. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
[TBL] [Abstract][Full Text] [Related]
16. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
17. Voxel-based distribution of metabolic impairment in corticobasal degeneration.
Garraux G; Salmon E; Peigneux P; Kreisler A; Degueldre C; Lemaire C; Destée A; Franck G
Mov Disord; 2000 Sep; 15(5):894-904. PubMed ID: 11009197
[TBL] [Abstract][Full Text] [Related]
18. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
19. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
